← Eichor
Condition: Cirrhosis Portal Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cirrhosis Portal

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
NA · 2 location(s) · University of Pennsylvania · NCT06136221Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
Phase N/A · 2 location(s) · University Medical Center Groningen · NCT07585890Microplastics, Cirrhosis and Portal Hypertension
Phase N/A · 2 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT07280390Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Phase 1 · 1 location(s) · Zydus Therapeutics Inc. · NCT06825559Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis
NA · 2 location(s) · Shanxi Provincial People's Hospital · NCT071160962D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07122622EUS-guided Response Assessment to NSBB
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06513195EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endosc
NA · 1 location(s) · Chinese University of Hong Kong · NCT05597488Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Phase 4 · 1 location(s) · Mansoura University · NCT07132515Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
Phase 1 · 1 location(s) · Zydus Therapeutics Inc. · NCT05045482Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection
NA · 2 location(s) · Northern Jiangsu People's Hospital · NCT07462091Underdilated-stent Technique Improves Post-TIPS Encephalopathy
NA · 2 location(s) · The Second Affiliated Hospital of Chongqing Medical Universi · NCT07349654EUS Guided Portal-systemic Pressure Gradient Measurement
Phase 1/Phase 2 · 1 location(s) · Chinese University of Hong Kong · NCT04633356Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced
Phase 2 · 1 location(s) · West China Hospital · NCT06859684The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial
Phase 1 · 1 location(s) · University of Chicago · NCT06871111In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Pl
Phase 3 · 1 location(s) · Green Cross Wellbeing · NCT06493799Multidimensional Frailty Assessment and Post-Transplant Outcomes in Liver Transplant Candidates
Phase N/A · 1 location(s) · Izmir Bakircay University · NCT07414095Screening of Patients With Hepatic Fibrosis or Cirrhosis B and C
NA · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06755632Empagliflozin in Patients With Cirrhosis and Ascites
Phase 2 · 1 location(s) · Yale University · NCT05726032Screening for Advanced Liver Fibrosis Using Non-invasive Tests in Primary Care
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT06119997Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Phase 4 · 1 location(s) · Asian Institute Of Medical Sciences · NCT07521332Siemens Biomarker Multi-modality
NA · 1 location(s) · Duke University · NCT07495332Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites
Phase 2 · 1 location(s) · Anahita Rabiee MD MHS · NCT06812390Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis
Phase N/A · 3 location(s) · Singapore General Hospital · NCT07438288TIPS in Patients With Decompensated Liver Cirrhosis
Phase N/A · 1 location(s) · Hannover Medical School · NCT04801290Functional Assessment in Liver Transplantation
Phase N/A · 12 location(s) · University of California, San Francisco · NCT03228290Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
NA · 2 location(s) · Mayo Clinic · NCT06425380Natural History of Advanced Chronic Liver Diseases
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07042308A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
Phase 3 · 1 location(s) · Beijing Continent Pharmaceutical Co, Ltd. · NCT07343778hepatomiR cACLD Study
Phase N/A · 1 location(s) · Karl Landsteiner University of Health Sciences · NCT06432582
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.